Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GEOFFREY L CHUPP

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1811970577
CMS profile
309470
Location
NEW HAVEN, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$148,399.55

75 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $67,813.17 24
GENZYME CORPORATION $29,321.58 17
AstraZeneca Pharmaceuticals LP $27,840.76 16
Regeneron Healthcare Solutions, Inc. $10,008.35 5
Merck Sharp & Dohme LLC $8,743.19 11
Takeda Pharmaceuticals U.S.A., Inc. $2,524.50 1
AstraZeneca UK Limited $2,148.00 1

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

75 matching records · $148,399.55 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 75 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 75.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $4,833.0012/18/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015923585 CMS
GENZYME CORPORATION $2,907.0012/12/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696531 CMS
GENZYME CORPORATION $150.4212/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696537 CMS
GENZYME CORPORATION $198.9212/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696543 CMS
GENZYME CORPORATION $14.8212/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696881 CMS
GENZYME CORPORATION $111.6712/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696911 CMS
GENZYME CORPORATION $893.1312/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696915 CMS
GENZYME CORPORATION $214.9012/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696923 CMS
GENZYME CORPORATION $6,783.0012/12/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696929 CMS
GENZYME CORPORATION $888.6612/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696935 CMS
GENZYME CORPORATION $214.9012/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696941 CMS
AstraZeneca Pharmaceuticals LP $805.5012/11/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011857311 CMS
GlaxoSmithKline, LLC. $54.2812/11/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001521075 CMS
GlaxoSmithKline, LLC. $339.2912/11/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001521521 CMS
AstraZeneca Pharmaceuticals LP $1,611.0012/08/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015799779 CMS
GlaxoSmithKline, LLC. $206.5312/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001522289 CMS
GlaxoSmithKline, LLC. $376.1712/07/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001521065 CMS
GlaxoSmithKline, LLC. $6.3912/01/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001521053 CMS
GENZYME CORPORATION $5,814.0011/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696519 CMS
GENZYME CORPORATION $1,902.0011/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696887 CMS
AstraZeneca Pharmaceuticals LP $2,685.0011/01/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011846077 CMS
GlaxoSmithKline, LLC. $7,160.2210/31/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001520489 CMS
GlaxoSmithKline, LLC. $7,160.2210/31/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001521531 CMS
GlaxoSmithKline, LLC. $48.2110/31/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001521771 CMS
GlaxoSmithKline, LLC. $1,625.0010/24/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001521147 CMS
Merck Sharp & Dohme LLC $2,092.5010/11/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048260655 CMS
GlaxoSmithKline, LLC. $10,400.0010/03/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001522229 CMS
AstraZeneca Pharmaceuticals LP $537.0009/12/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011870019 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,524.5008/28/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055369499 CMS
AstraZeneca Pharmaceuticals LP $537.0008/01/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011418689 CMS
Regeneron Healthcare Solutions, Inc. $258.4008/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026999125831 CMS
AstraZeneca Pharmaceuticals LP $2,685.0007/26/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014208549 CMS
AstraZeneca Pharmaceuticals LP $2,685.0007/26/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014385133 CMS
GENZYME CORPORATION $4.1107/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696707 CMS
GlaxoSmithKline, LLC. $6,500.0006/27/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001521415 CMS
AstraZeneca Pharmaceuticals LP $2,148.0006/26/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015838151 CMS
GlaxoSmithKline, LLC. $84.4106/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001521807 CMS
AstraZeneca UK Limited $2,148.0005/31/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261017082095 CMS
AstraZeneca Pharmaceuticals LP $30.8505/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015005731 CMS
GENZYME CORPORATION $6,112.5005/22/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696943 CMS
AstraZeneca Pharmaceuticals LP $134.4105/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016030713 CMS
AstraZeneca Pharmaceuticals LP $20.0005/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016221751 CMS
GENZYME CORPORATION $38.2205/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696449 CMS
GENZYME CORPORATION $3,056.0005/20/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696753 CMS
AstraZeneca Pharmaceuticals LP $5,907.0005/19/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014685117 CMS
GENZYME CORPORATION $17.3305/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049696677 CMS
GlaxoSmithKline, LLC. $13,000.0005/18/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001521407 CMS
GlaxoSmithKline, LLC. $52.3205/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001521567 CMS
GlaxoSmithKline, LLC. $37.4305/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001521819 CMS
GlaxoSmithKline, LLC. $116.0005/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001522267 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $294,814.35 222
PY2020 $135,672.32 90
PY2021 $238,712.59 163
PY2022 $234,108.18 156
PY2023 $148,399.55 75
PY2024 $110,299.09 59
PY2025 $73,010.21 56

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
GEOFFREY L CHUPP, NPI 1811970577. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1811970577.
APA 7
IndustryPayments. (2026). GEOFFREY L CHUPP, NPI 1811970577 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1811970577
Bluebook
GEOFFREY L CHUPP, NPI 1811970577, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1811970577.

Source: Centers for Medicare & Medicaid Services, Open Payments.